arrow
Back
Р

Роберто Пили

Roswell Park Comprehensive Cancer Center

74H-index
698Paper Count
1.9WCitation Count
Published Papers 159
Publication Date
Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients' Overall Burden of Illness
err2025-04-06
err0
errOAAI
errMohan, Minu Ponnamma; Epstein, Joel B.; Meleveedu, Kapil S.; Padhi, Parikshit; Pili, Roberto; Satheeshkumar, Poolakkad S.
errShare
errSave
Correlates of Perceived Illness Severity and Terminality in Advanced Lung and Prostate Cancer
err2025-04-01
err0
PREAI
errDi Palmo, Michaela; Secinti, Ekin; Krueger, Ellen; Hanna, Nasser H.; Adra, Nabil; Durm, Gregory A.; Einhorn, Lawrence; Pili, Roberto; Jalal, Shadia I.; Mosher, Catherine E.
errShare
errSave
errShare
errSave
Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects
err2024-09-01
err0
PREAI
errKyriakopoulos, C.; Chatta, G.; Laccetti, A. L.; Iannotti, N.; Sokolova, A. O.; Hotte, S. J.; Tutrone, R.; Markowski, M. C.; Nordquist, L. T.; Pili, R.; Saad, F.; Zhang, J.; Villaluna, K.; Younginger, B.; Le Moigne, R.; Cesano, A.
errShare
errSave
The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma
err2024-03-22
err0
PREAI
errJawadwala, Abbas; Rupert, Christopher; Adelaiye-Ogala, Remi; Pili, Roberto; Chintala, Sreenivasulu; Orillion, Ashley; Elbanna, May; Damayanti, Nur; Delle Fontane, Ilaria
errShare
errSave
Metabolic rewiring induced by protein or calorie restriction provides unique therapeutic vulnerabilities in translocation and select clear cell renal cell carcinomas
err2024-03-22
err0
PREAI
errOrsi, Sabrina A.; Rupert, Christopher; Colligan, Sean; Chang, Musea; Jawadwala, Abbas; Delle Fontane, Ilaria; de Nigris, Filomena; Pili, Roberto
errShare
errSave
The antihistamine terfenadine inhibits TFE3 dimerization, has antitumor activity and synergizes with tyrosine kinase inhibitors in translocation renal cell carcinoma
err2024-03-22
err0
PREAI
errDelle Fontane, Ilaria; Cordova, Ricardo; Rupert, Christopher; Orsi, Sabrina; Jawadwala, Abbas; Heppener, David E.; Pili, Roberto
errShare
errSave
Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
err2023-10-01
err1
PREAI
errLaccetti, A. L.; Chatta, G.; Kyriakopoulos, C.; Iannotti, N.; Hotte, S. J.; Markowski, M. C.; Pili, R.; Vuky, J.; Zhang, J.; Saad, F.; Villaluna, K.; Younginger, B.; Le Moigne, R.; Cesano, A.
errShare
errSave
A mechanistic study of the TFE3-splicing machinery gene fusions reveals a new druggable target for translocation renal cell carcinoma
err2023-08-15
err0
PREAI
errDelle Fontane, Ilaria; Damayanti, Nuri; Rupert, Christopher; Heppner, David E.; Pili, Roberto
errShare
errSave
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma
err2023-08-15
err0
PREAI
errOrsi, Sabrina; Rupert, Christopher; Pili, Roberto; De Nigris, Filomena
errShare
errSave
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
err2023-05-26
err8
errOAAI
errRupert, Christofer; Aversana, Carmela Dell'; Mosca, Laura; Montanaro, Vittorino; Arcaniolo, Davide; De Sio, Marco; Bilancio, Antonio; Altucci, Lucia; Palinski, Wulf; Pili, Roberto; de Nigris, Filomena
errShare
errSave
Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation
err2023-05-01
err9
errOAAI
errHadisurya, Marco; Lee, Zheng-Chi; Luo, Zhuojun; Zhang, Guiyuan; Ding, Yajie; Zhang, Hao; Iliuk, Anton B.; Pili, Roberto; Boris, Ronald S.; Tao, W. Andy
errShare
errSave
GCN2 eIF2 kinase and p53 coordinate amino acid homeostasis and metabolism in prostate cancer
err2023-04-04
err0
PREAI
errCordova, Ricardo A.; Sommers, Noah R.; Klunk, Angela J.; Mohiuddin, Haroon M.; Pili, Roberto; Wek, Ronald C.; Staschke, Kirk A.
errShare
errSave
A mechanistic study of the TFE3-splicing machinery gene fusions reveals a new druggable target for translocation renal cell carcinoma
err2023-04-04
err0
PREAI
errDamayanti, Nur; Orsi, Sabrina; Cordova, Ricardo; Rupert, Christopher; Shen, Li; Linehan, William Marston; Staschke, Kirk; Hollenhorst, Peter; Heppner, David; Pili, Roberto
errShare
errSave
EZH2 mediated kinome reprogramming drives AR phosphorylation and activation in receptor tyrosine kinase inhibitors resistant renal carcinoma models
err2023-04-04
err0
PREAI
errRupert, Christopher; Metcalf, Stephanie; Rajendran, Saranya; Colligan, Sean; Hollenhorst, Peter; Pili, Roberto
errShare
errSave
Alternate-day fasting enhances the activity of anti-androgen therapy in prostate cancer models
err2023-04-04
err0
PREAI
errCordova, Ricardo; Elbanna, May; Klunk, Angela; Rupert, Christopher; Shen, Li; Wang, Yanqing; Goodrich, David; Wek, Ron; Staschke, Kirk; Fontana, Luigi; Pili, Roberto
errShare
errSave
errShare
errSave
Developing HDAC inhibitors as immunomodulators
err2023-04-04
err0
PREAI
errColligan, Sean; Shen, Li; Rupert, Christopher; Bard, Jonathan; Pili, Roberto
errShare
errSave
Tumor PD-L1 induction associated with dietary protein restriction is modulated by PERK activation
err2023-04-04
err0
PREAI
errCordova, Ricardo; Colligan, Sean; Rupert, Chris; Wek, Ronald; Staschke, Kirk; Pili, Roberto
errShare
errSave